字号·· | 护眼
英国广播公司

脑癌患者要求对化疗丑闻展开公开调查Brain cancer patients at UHCW demand public inquiry into chemotherapy scandal

点「原文对照」整页切到原文,或双击某段只看那段的原文。

贝基·琼斯因一种她并未患上的癌症接受了11年化疗,她说这种治疗“像发糖果一样被随意发放”。Becky Jones who had 11 years of chemotherapy for a cancer she did not have said treatment was "handed out like sweets"

报告建议,应与政府讨论对受影响患者进行更广泛的审查。据大卫·兰布(David Lumb)和希娜兹·汗(Shehnaz Khan)报道,在接受英国国民保健服务(NHS)信托机构照护期间遭受严重伤害的脑癌患者,在审查发现相关情况后,呼吁开展公开调查,要求对多年接受不必要化疗的情况进行问责。

A wider review of affected patients should be discussed with the government, the report recommends. By David Lumb, Shehnaz Khan Brain cancer patients who were given years of unnecessary chemotherapy are calling for a public inquiry, after a review found people were severely harmed under an NHS trust's care.

部分患者被误诊,另一些患者被告知,如果停止使用替莫唑胺(TMZ)治疗就会死亡,而事实并非如此。

Some were misdiagnosed while others were told if they stopped temozolomide (TMZ) treatment they would die, despite this not being true.

英国皇家医师学会(RCP)调查了考文垂和沃里克郡大学医院(UHCW)NHS信托机构的20个病例。

The Royal College of Physicians (RCP) investigated 20 cases at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust.

该药物通常应服用六个月,但在一个病例中,伊恩·布朗(Ian Brown)教授的一名患者在13年期间接受了超过100个周期的化疗。

The drug is typically meant to be taken for six months but in one case a patient of Prof Ian Brown was given more than 100 cycles of chemotherapy over a period of 13 years.

贝基·琼斯(Becky Jones)接受了一种她并未患有的癌症长达11年的治疗,她告诉BBC,她对“化疗像发糖一样随意发放”感到“极度厌恶”。

Becky Jones, who had 11 years of the treatment for a cancer she did not have, has told the BBC she was "absolutely disgusted" that "chemotherapy was dished out like it was sweets".

“我有两个年幼的孩子,一想到我可能曾经不在孩子们未来身边,我每天都感到心碎,而这一切都源于一个人,”这位34岁的女性补充道。

"I have two young children and to think once upon a time I might not have been there for their future kills me every day and it's all down to one person," the 34-year-old added.

考文垂和沃里克郡大学医院NHS信托基金会已道歉。University Hospitals Coventry and Warwickshire NHS Trust has apologised

她是对该NHS信托机构提起法律诉讼的40多名患者之一。这位两个孩子的母亲在21岁时被告知患有4级胶质母细胞瘤,仅剩6至12个月的生命。

She is one of more than 40 patients taking legal action against the NHS Trust. The mum-of-two was 21 when she was told she had a grade 4 glioblastoma and six to 12 months to live.

在接受超过100个周期的化疗后,发现她从未患有脑肿瘤,其影像学检查结果与肿瘤样脱髓鞘一致,这是一种较不严重的病变。她谈到该报告时说:“调查结果比我预想的还要糟糕。

After more than 100 cycles of chemotherapy it was found she had never had a brain tumour and that her imaging was consistent with tumefactive demyelination, a less serious lesion. She said of the report: "The findings are worse than I ever expected them to be.

“必须开展全国性调查,并加强监管,以免此类事情再次发生在任何人身上。

"A national inquiry needs to happen and things need to be tightened up so it can't happen to anyone else.

“除非该信托机构承认其错误并承担责任,否则我认为自己永远无法获得释然。我想要答案。”

"I don't think I'll ever find closure until the Trust accept what they have done wrong and are held accountable. I would like answers."

该审查报告于周三发布,由该信托机构在其一名医生退休后委托开展。

The review, released on Wednesday, was commissioned by the trust following the retirement of one of its doctors.

布朗教授在RCP的报告中被称为Y博士,他没有参与审查,并在BBC记者上门采访时拒绝发表评论。

Prof Brown, referred to as Dr Y in the RCP's report, did not take part in the review and refused to comment when approached by the BBC at his home.

考文垂和沃里克郡大学医院国家医疗服务体系信托(UHCW)就其神经肿瘤科在退休临床肿瘤科医生布朗的照护下出现的“失误”道歉。

University Hospitals Coventry and Warwickshire (UHCW) NHS Trust has apologised for "failures" within its neuro-oncology service under the care of the retired clinical oncologist.

首席执行官安迪·哈迪教授和信托主席苏·诺伊斯在一份声明中说:“这远低于我们患者应得的标准,也远低于我们期望的标准。我们让您失望了,对此我们深表歉意。”布朗于1996年至2024年在该机构任职,同事们在他2023年12月退休后,将其患者移交给他们时,对其医疗实践提出了担忧。

Chief executive Professor Andy Hardy and trust chair Sue Noyes said in a statement: "This is far below the standards our patients deserve and that we expect. We let you down, and for that we offer our sincere apologies." Brown was employed there from 1996 to 2024 and concerns over his practice were raised by colleagues when his patients were handed over to them when he retired in December 2023.

已于2024年退休的伊恩·布朗教授在审查报告中被称为Y医生。Prof Ian Brown, who retired in 2024, is referred to as Dr Y in the review

医护人员发现,有些人长期反复接受替莫唑胺(TMZ)治疗,这违背了标准做法和国家指南。

Medics found people on long-term repeated cycles of TMZ, against standard practice and national guidelines.

一些患者在癌症进展后仍继续接受治疗,而此时转为最佳支持性护理以缓解症状本应是更好的选择。

Some patients had also been left on treatment despite their cancer progressing, when moving to the best supportive care for their symptoms would have been a better choice.

超过80名接受TMZ治疗的患者,TMZ是一种有时用于治疗胶质母细胞瘤和星形细胞瘤脑肿瘤的化疗药物,通常应在放疗后服用六个疗程,通常为期六个月,但一些患者告诉BBC,他们接受了多年的治疗。

More than 80 treated TMZ, a chemotherapy drug that is sometimes used for glioblastoma and astrocytoma brain tumours, should usually be taken post radiotherapy for six cycles, usually over six months, but some patients have told the BBC they received it for many years.

审查警告称,受影响的患者可能更多,2017年至2023年间有83名患者接受了延长的TMZ治疗。

The review warned there may be many more affected patients, with 83 receiving extended TMZ treatment between 2017 and 2023.

总体而言,RCP审查了布朗教授照护下的20个病例,尽管受影响的患者人数(包括已故患者)更多。

Overall, the RCP examined 20 cases of care under Prof Brown, though the number of patients affected, including those who have died, is higher.

在其他建议中,RCP表示,任何对接受该治疗且已故患者的更广泛审查,都应与卫生和社会福利部讨论。

Among other recommendations, the RCP said that any wider review of patients who received the treatment and have since died should be discussed with the Department of Health and Social Care.

报告称:“有一大批已故患者接受了这种非标准化疗方案,他们可能潜在地受到了伤害。”

"There is a large cohort of deceased patients who have received this non-standard chemotherapy regime, who may potentially have come to harm," the report said.

“对每位患者进行复查将是一项重大且成本高昂的工作。该信托应决定此举是否恰当,若恰当,则应与卫生和社会护理部(DHSC)和/或英格兰国家医疗服务体系(NHS England)商讨此类复查将如何开展。”

"To review every patient would be a significant and costly undertaking. The Trust should determine whether such a step is appropriate, and if so, discuss with the DHSC and/or NHS England how such a review would proceed."

马克·波尔顿在接受10年治疗后发现自己被误诊。After 10 years of treatment, Mark Poulton found out he had been wrongly diagnosed

来自雷迪奇的三个孩子的父亲马克·波尔顿表示,他在接受了长达十年的化疗后,两年前才发现自己被误诊,从此陷入“持续疼痛”,并伴有抑郁发作。

Father-of-three Mark Poulton, from Redditch, said he had been left in "constant pain" with spells of depression after undergoing chemotherapy for a decade, only to discover two years ago that he had been misdiagnosed.

这位54岁的患者告诉英国广播公司(BBC):“我感到愤怒,因为我经历了10年的替莫唑胺治疗,而我可能本不该接受这种治疗,报告也证实了这一点。

The 54-year-old told the BBC: "I feel angry that I've gone through 10 years of TMZ that I probably shouldn't have done and the report backs that.

“你一旦确诊患有任何类型的癌症,就会觉得天塌了下来,接着你去医院,觉得自己在正确的地方,感到安全,结果10到12年后才发现,你被那个辜负了我和其他涉事患者的系统所伤害。

"You get a cancer diagnosis of any sort and you feel you will collapse, then you go to a hospital and you're in the right place, you feel safe, only to find out 10 to 12 years later that you were abused by the system that failed me and the other patients involved.

“必须采取更多行动,不能就此随着这份复查报告结束。我们需要行动,以免悲剧重演。”

"More needs to be done, it can't end here with this review. We need action so it doesn't happen again."

2014年,他被告知患有少突胶质细胞瘤,这是一种侵袭性脑肿瘤,但2024年他得知自己实际上患有星形细胞瘤,这是另一种类型的癌症。

In 2014 he was told he had oligodendroglioma, an aggressive brain tumour, but found out in 2024 that he actually had astrocytoma, a different type of cancer.

复查还指出,其他患者在接受数年非标准化疗后,面临“显著的终身风险”,可能罹患继发性癌症及其他健康问题。

The review also highlighted other patients who were exposed to a "significant lifetime risk" of developing secondary cancers and other health problems after several years of non-standard chemotherapy.

报告称,另一名患者服用该药物长达10年,经历了“显著毒性反应”,包括持续疲劳、恶心,以及由治疗化疗引起的恶心呕吐的药物导致的“严重发作”的眼部带状疱疹和溢乳。复查指出,一些患者被隐性或显性地告知停止治疗将有害。在一些案例中,也有证据显示患者被给予了误导性信息。

It said another patient, who received the drug for 10 years, experienced "significant toxicity", including ongoing fatigue, nausea and a "severe episode" of ophthalmic shingles and galactorrhoea caused by a drug prescribed to treat chemotherapy-induced nausea and vomiting. Some patients were advised implicitly and explicitly that stopping treatment would be harmful, the review said. There was also evidence in some cases of patients being given misleading information.

审查小组在访谈中听到,少数患者曾要求停止治疗,临床护士 N 先生随后与布朗教授讨论并据此采取了行动,但在所审查的病例中未见相关证据。

The review team heard in interviews that a small number of patients had requested discontinuation of their treatment, which clinical nurse Mr N then discussed with Prof Brown and acted upon, however no evidence of this was seen in the cases reviewed.

他们补充说:“在一例中,当患者对治疗提出质疑时,N 先生告诉他们,Y 医生(布朗教授)‘依法必须’继续治疗。”

"In one case when the patient questioned their treatment, they were told by Mr N that Dr Y (Prof Brown) was 'legally bound' to continue it," they added.

请在 BBC Sounds、Facebook、X 上关注 BBC Coventry & Warwickshire。

Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and

阅读媒体原文 ↗